Tandem Diabetes Care, Inc. received U.S. Food and Drug Administration (FDA) approval on 11/16/11 to market the t:slim Insulin Delivery System. The t:slim is one of the first insulin pumps to be cleared under the FDA’s new Infusion Pump Improvement Initiative. It has a revolutionary pump system powered by pressure with a microdosing mechanism that can deliver doses as small as 0.001 u.
The SOLO MicroPump Insulin Delivery System is a patch pump originally made by Medingo and purchased by Roche in 2010. Solo received FDA approval in 2009 and is expected to be available in 2012. The system has 4 parts: a micropump composed of reusable electronics plus an insulin reservoir, a remote, and a cradle.
The Debiotech JewelPump is a disposable patch pump with some similarities to the current Omnipod, as well as other patch pumps on the horizon. Debiotech, a Swiss company, teamed with ST Microelectronics to create this sleek pump system. Like most patch pumps, a separate controller is required to deliver bolus insulin doses. It use a microelectromechanical (MEMS) pumping system, that allows the pump to be kept small and light.
The Cellnovo semi-patch pump (patch pump with a nearby infusion site) got a lot of attention in 2009 when it was first announced because of it's small size and iPhone like handset. Cellnovo, a London based company, has now joined forces with Osaka, Japan based Nipro Diagnostics, a blood glucose meter company, for integration of a meter into the Cell-Novo controller for the pod.
The V-Go is a simple-to-use, once-daily, disposable insulin delivery device that provides a preset basal rate and on-demand bolus dosing. The V-Go allows you to conveniently and discreetly deliver insulin. The h-Patch technology is also being developed to serve as a launching platform for applications across a wide spectrum of medical needs. The original h-Patch product (BIDS) received 510(k) clearance in 2005 and based on improvements to this technology and its filling device, a new 510(k) for the V-Go and its Filling device was submitted and is currently under review by the FDA.
The diabetes technology area has grown so much over the years. There are a number of companies jumping into the field with different ways to pump insulin. We've listed a few below.
The Cellnovo patch pump has garnered a lot of attention since it's initial mention in 2009. With it's small size and well designed handset, pumpers can't wait to get their hands on this device.
Patch pump technology has been on the verge of breaking through for several years and now it may actually happen. Patch pumps are becoming popular because they avoid the tethered approach of current pumps. Instead of having your pump connected to your body via an infusion set and tubing, the patch pump is worn directly on the body, discreetly attached at the infusion site and wirelessly controlled with a separate device.
Diabetes care has improved with many of the technological advances in the field. From improvements in insulin pumps and infusion sets to the implementation of continuous glucose monitors, technology is helping deal with diabetes easier than ever before. More technology companies are getting involved in diabetes everyday. In this section, you will find information on:
Sign up for the Diabetesnet.com newsletter.